Synthetic Biology in Medical Market

The global Synthetic Biology in Medical market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.

Genome Engineering Segment to Reach $ Million by 2032, with a % CAGR in next six years.

The global key manufacturers of Synthetic Biology in Medical include Thermo Fisher Scientific, Novozymes, Merck KGaA, Agilent Technologies, Arzeda, Codexis, Ginkgo Bioworks, Precigen and Genscript Biotech Corp, etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Synthetic Biology in Medical companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Synthetic Biology in Medical Market, by Type, 2018-2023, 2023-2032 ($ millions)

Global Synthetic Biology in Medical Market Segment Percentages, by Type, 2022 (%)

• Genome Engineering
• NGS
• Cloning and Sequencing

Global Synthetic Biology in Medical Market, by Application, 2018-2023, 2023-2032 ($ millions)

Global Synthetic Biology in Medical Market Segment Percentages, by Application, 2022 (%)

• Drug Discovery And Therapeutics
• Pharmaceuticals
• Other

Global Synthetic Biology in Medical Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions)

Global Synthetic Biology in Medical Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Synthetic Biology in Medical revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Synthetic Biology in Medical revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Novozymes
• Merck KGaA
• Agilent Technologies
• Arzeda
• Codexis
• Ginkgo Bioworks
• Precigen
• Genscript Biotech Corp
• TeselaGen
• Integrated DNA Technologies
• Twist Bioscience
• New England Biolabs

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports